MyEczemaTeam Medical Reviewer | Brian S. Kim, M.D.
Posted on February 21, 2024
Brian S. Kim, M.D.
Brian S. Kim, M.D.
Dr. Brian S. Kim is co-director for the Center for the Study of Itch and Sensory Disorders and associate professor of medicine at Washington University School of Medicine in St. Louis. Key discoveries from his laboratory include the first identification of group 2 innate lymphoid cells (ILC2s) in the skin of both mice and humans, and their role in the pathogenesis of atopic dermatitis or eczema. Most recently, he has discovered how the immune system directly regulates sensory neurons to modulate the sensation of itch and how natural killer cells may be used as an immunotherapy strategy for atopic dermatitis. These studies have revealed novel therapeutic strategies which have led to successful clinical trials for new drugs for atopic dermatitis. He has multiple patents pending that led to the formation of Nuogen Pharma, Inc. that is developing JAK inhibitors for chronic itching.
Education
University of Washington School of Medicine (M.D.)
University of Pennsylvania (Residency)
American Academy of Dermatology (Fellowship)
Certifications
Certified by the American Board of Dermatology
Missouri Board of Registration for the Healing Arts
Professional Accolades
American Skin Association Research Achievement Award in Discovery (2021)
Stephen I. Katz, M.D., Ph.D., International Lectureship Award, Society for Investigative Dermatology (2021)
International League of Dermatological Societies Young Dermatologist Achievement Award (2019)
American Dermatological Association Young Investigator Award (2019)
Board of reviewing editors at eLife
Scientific advisory board at Cell Reports Medicine
Section editor for the Journal of Immunology
Review editor for Frontiers in Immunology
Affiliations
Icahn School of Medicine at Mount Sinai
Mark Lebwohl Center for Neuroinflammation and Sensation
